Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Endocrine toxicities of immunotherapy

Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales
Endocrine toxicities of immunotherapy ( Dr Ricky Frazer - Velindre Cancer Centre, Cardiff, Wales )
13 Jan 2020

Recognising sepsis in cancer patients

Dr Ron Daniels - Sepsis Trust, Birmingham, UK
Recognising sepsis in cancer patients ( Dr Ron Daniels - Sepsis Trust, Birmingham, UK )
13 Jan 2020

Endocrine dysfunction in patients receiving immunotherapy

Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK
Endocrine dysfunction in patients receiving immunotherapy ( Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK )
13 Jan 2020

Advanced communication training and regional primary cancer care

Una Cardin - Western Health & Social Care Trust, Londonderry, Northern Ireland
Advanced communication training and regional primary cancer care ( Una Cardin - Western Health & Social Care Trust, Londonderry, Northern Ireland )
13 Jan 2020

24-hour triage assessment in Taiwan

Yan-Ting Liou - National Taiwan University, Taipei, Taiwan
24-hour triage assessment in Taiwan ( Yan-Ting Liou - National Taiwan University, Taipei, Taiwan )
13 Jan 2020

Shortage of nurses will result in poor patient care and safety

Ali Hodge - The Royal Marsden NHS Foundation Trust, London, UK
Shortage of nurses will result in poor patient care and safety ( Ali Hodge - The Royal Marsden NHS Foundation Trust, London, UK )
13 Jan 2020

UKONS 2019 highlights

Dr Verna Lavender - Guy's and St Thomas' NHS Foundation Trust, London, UK
UKONS 2019 highlights ( Dr Verna Lavender - Guy's and St Thomas' NHS Foundation Trust, London, UK )
13 Jan 2020

Breast cancer screening and treatment in Brazil

Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre, Brazil
Breast cancer screening and treatment in Brazil ( Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre, Brazil )
19 Dec 2019

Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019

Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women

Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women ( Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA )
19 Dec 2019

Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer

Prof William Symmans - MD Anderson Cancer Center, Houston, Texas
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer ( Prof William Symmans - MD Anderson Cancer Center, Houston, Texas )
19 Dec 2019

Oral paclitaxel with encequidar in metastatic breast cancer

Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
Oral paclitaxel with encequidar in metastatic breast cancer ( Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras )
19 Dec 2019